Skip to content

Effects of The Telerehabilitation-Based Exercise Program in Liver Transplant Patients

Effects of The Telerehabilitation-Based Exercise Program On Muscle Strength, Exercise Capacity and Fatigue Levels in Liver Transplant Patients

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07425314
Enrollment
140
Registered
2026-02-20
Start date
2024-10-12
Completion date
2025-11-28
Last updated
2026-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Capacity, Liver Transplantation, Muscle Weakness, Postoperative Recovery

Keywords

Physiotherapy, Liver Transplantation, Telerehabilitation, Functional Capacity, Fatigue

Brief summary

This randomized controlled study aims to evaluate the effects of a telerehabilitation-based exercise program on muscle strength, exercise capacity, fatigue level, and cognitive status in adult liver transplant recipients. Liver transplantation is a major surgical procedure, and patients may experience reduced physical capacity, muscle weakness, and fatigue during recovery. Exercise-based rehabilitation may help improve these outcomes, but access to in-person rehabilitation programs may be limited after discharge. Participants will be randomly assigned to either a control group receiving routine post-transplant care or an intervention group participating in a supervised telerehabilitation exercise program. The intervention consists of a 12-week program conducted twice weekly via video communication with a physiotherapist. Outcomes will be assessed at baseline and after completion of the program. The study seeks to determine whether a structured, remotely supervised exercise program can improve functional recovery and reduce fatigue in liver transplant patients, potentially offering an accessible rehabilitation option after hospital discharge.

Detailed description

Liver transplantation is a complex surgical procedure that requires a structured recovery process extending from the pre-transplant period through hospitalization and post-discharge phases. After transplantation, patients frequently experience reduced physical capacity, decreased muscle strength, fatigue, and functional limitations that may negatively affect quality of life and recovery. Early and structured rehabilitation interventions are therefore considered important components of post-transplant care.

Interventions

BEHAVIORALTelerehabilitation Exercise Group

Participants in this group received a structured telerehabilitation-based exercise program delivered under real-time supervision by a physiotherapist. The intervention lasted 12 weeks and was conducted twice weekly via video communication. Each session lasted approximately 30-45 minutes and included warm-up exercises, posture and breathing exercises, isometric strengthening exercises for upper and lower extremities, functional exercises such as sit-to-stand, and walking training, followed by cool-down and stretching. Exercise intensity was maintained at a moderate level based on perceived exertion, and progression was applied throughout the program by increasing repetitions and duration to ensure adaptation and safety. Participants were initially instructed face-to-face before discharge and then continued the program remotely after discharge.

Sponsors

Hasan Kalyoncu University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Participants were randomly assigned to one of two parallel groups. The intervention group received a structured telerehabilitation-based exercise program in addition to routine post-transplant care, while the control group continued routine daily activities without a supervised exercise intervention. The study followed a parallel assignment design in which participants remained in their allocated group throughout the 12-week intervention period, and outcomes were assessed at baseline and post-intervention.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult liver transplant recipients aged 18 years or older * Medically stable and cleared for participation in an exercise program * Able to communicate and cooperate with the researcher * Literate and able to understand instructions * No orthopedic or neurological condition that would limit exercise participation * Approximately one month post-discharge following liver transplantation * Willing to participate and provide informed consent

Exclusion criteria

* Presence of medical conditions that contraindicate exercise participation * Severe cardiovascular, respiratory, neurological, or musculoskeletal disorders that could interfere with the exercise program * Cognitive impairment preventing understanding of instructions or participation in assessments * Postoperative complications requiring activity restriction * Participation in another structured exercise or rehabilitation program during the study period * Refusal or inability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
6-Minute Walk Test (6MWT) DistanceBaseline (pre-intervention) and end of the 12-week intervention periodChange in functional exercise capacity measured by the distance (meters) walked during the 6-minute walk test.
Fatigue Severity ScaleBaseline (pre-intervention) and end of the 12-week intervention periodChange in fatigue severity measured using the Fatigue Severity Scale (FSS). Total scores range from 9 to 63, with higher scores indicating greater fatigue severity.

Secondary

MeasureTime frameDescription
Peripheral Oxygen Saturation (SpO₂)Baseline and end of 12 weeksChange in oxygen saturation measured by pulse oximeter.
Montreal Cognitive Assessment (MoCA) ScoreBaseline and end of 12 weeksChange in cognitive function assessed using the Montreal Cognitive Assessment (MoCA). Total scores range from 0 to 30, with higher scores indicating better cognitive function.
Heart RateBaseline and end of 12 weeksChange in heart rate measured using a pulse oximeter device.

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATORIlker Demir, PhD

Inonu University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026